A Case of Synchronous Colorectal Carcinoma Manifested as Three Separate Colon Masses by Imperatore, Alyssa, DO et al.
Rowan University 
Rowan Digital Works 
Stratford Campus Research Day 22nd Annual Research Day 
May 3rd, 8:00 AM 
A Case of Synchronous Colorectal Carcinoma Manifested as 
Three Separate Colon Masses 
Alyssa Imperatore DO 
Rowan University SOM 
Linda Szczurek DO, FACOS 
Rowan University SOM 
Alan Shienbaum DO 
Rowan University SOM 
Follow this and additional works at: https://rdw.rowan.edu/stratford_research_day 
 Part of the Digestive System Diseases Commons, and the Neoplasms Commons 
Let us know how access to this document benefits you - share your thoughts on our feedback 
form. 
Imperatore, Alyssa DO; Szczurek, Linda DO, FACOS; and Shienbaum, Alan DO, "A Case of Synchronous 
Colorectal Carcinoma Manifested as Three Separate Colon Masses" (2018). Stratford Campus Research 
Day. 4. 
https://rdw.rowan.edu/stratford_research_day/2018/may3/4 
This Poster is brought to you for free and open access by the Conferences, Events, and Symposia at Rowan Digital 
Works. It has been accepted for inclusion in Stratford Campus Research Day by an authorized administrator of 
Rowan Digital Works. For more information, please contact brush@rowan.edu. 
Synchronous Colorectal Carcinoma Manifested as Three Separate Colon 
Masses: A Case Report and Review of Literature 
Colorectal cancer is the second leading cause of cancer-related 
deaths in the United States amongst cancers that affect both 
genders. A small entity of this common disease is synchronous 
colorectal carcinoma. Research on this topic is becoming more 
prevalent, however, more answers are still needed. Below is a case of 
synchronous colorectal carcinoma in which three separate colon 
masses were discovered on initial presentation. 
• Hemoglobin found to be 5.0 with iron deficiency and heme-occult 
positive stool: two units packed red blood cells transfused  
• Gastroenterology consulted: plan for EGD/colonoscopy 
• V/Q scan ruled out PE, anticoagulation held for possible GI bleed 
• Taken to endoscopy suite: three polypoid lesions in rectum and 
three separate colon masses located in the cecum, sigmoid colon 
and rectosigmoid seen; all of which were biopsied and inked 
• CT scan post-procedure: 4.2x2.7 cm mass at the cecum in region of 
terminal ileum and areas of bowel wall thickening at proximal 
descending colon, proximal sigmoid colon, and distal rectosigmoid 
colon 
• General surgery consulted: plan for OR after multidisciplinary 
discussion 
• Pre-operative CEA 2.19 
• Preliminary pathology: high grade dysplasia in the cecum and 
carcinoma in situ in rectal polyp 
• Taken to the operating room: rectal exam under anesthesia and 
laparoscopic subtotal colectomy 
• Final pathology post-operatively: moderately differentiated invasive 
adenocarcinoma arising from tubulovillous adenomas with lymph-
vascular and perineural invasion, five out of twelve lymph nodes 
sampled were involved 
• Immunohistochemistry stains for mismatch repair proteins: low 
probability of microsatellite instability 
• Uncomplicated post-operative course and stable for discharge on 
post-op day four 
CONCLUSION 
INTRODUCTION 
Synchronous colorectal cancer may be more prevalent than even documented 
secondary to not fully diagnosing or patients undergoing palliative surgery prior to 
complete diagnosis. This is a topic that could benefit from a large research 
experiment or meta-analysis to better answer the question as to how to effectively 
manage these patients. 
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CASE PRESENTATION 
78 year-old female who presented with shortness of breath on 
exertion for two weeks. She complained of associated lightheaded-
ness and a remote history of intermittent black stools but no bright 
red blood per rectum or hematemesis. Past medical history 
significant for PE currently on Xarelto and left-sided breast cancer 
that was treated with neoadjuvant chemotherapy two years prior. 
Patient has never had a colonoscopy or EGD. Family history pertinent 
for sister dying of stomach cancer 30 years ago but no known history 
of inflammatory bowel disease. Physical exam on presentation was 
benign with no abdominal tenderness or organomegaly. Vital signs 
significant for sinus tachycardia.  
DISCUSSION 
Synchronous colorectal cancer is defined as two or more primary adenocarcinomas 
detected within a six-month time frame that are distinctly separate. The overall 
incidence has been documented as low as 0.5% and has been reported to be as 
high as 8%. This range depends on whether patients with polyposis syndromes or 
inflammatory bowel disease are included or not. It has been shown that those 
with these disorders have a higher predilection to developing synchronous 
colorectal carcinomas, with a common association to microsatellite instability. This 
case had a low probability of this factor. Among those with synchronous colorectal 
cancer, only less than 15% are patients with three or more primary lesions and the 
highest reported tumor count in a single patient thus far is six lesions. Varying data 
has been published on factors associated with this presentation. The most 
common information states that synchronous tumors appear to occur more with 
advanced age. However, these still occur in the middle-aged population.  
  
It can be argued that the most important aspect of synchronous colorectal cancer 
is diagnosis. It is common to miss another lesion on imaging or if a full colonoscopy 
cannot be completed prior to taking the patient to the operating room. Being able 
to inspect the entirety of the bowel is a vital step in determining how to proceed 
with treatment, particularly to what extent of surgery to perform. 
  
Surgery is a major component of treatment of synchronous colorectal cancer. The 
main goal of surgery is an en bloc resection with adequate margins as well as 
removing the regional lymph node basin. If this cannot be achieved, palliative 
surgery is another option for many patients. There is some controversy over what 
procedure a patient should undergo. Some studies conclude that an extended 
resection does not improve overall survival, whereas other studies found results 
stating that a radical resection can increase survival rate if diagnosed early enough. 
Along those lines, a higher risk of post-operative complications and reoperation is 
associated with this population. But most importantly, this does not confer a 
higher 30-day mortality rate when compared to solitary tumors. Five-year survival 
rate has been reported to be as high as 53%, almost equal to that of solitary 
tumors. Further research is needed to hone in on the most appropriate surgical 
treatment for these multiple lesions. 
  
Follow-up is another key factor in patients with synchronous colorectal carcinoma, 
as they are found to have a higher incidence of associated polyps that can undergo 
neoplastic transformation and a higher rate of metachronous cancer than those 
with single tumors. Therefore, continued management with close follow-up 
colonoscopy and imaging is critical in keeping any future progression at bay. 
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CLINICAL COURSE 
Final Pathology (2x magnification): A. Cecal adenocarcinoma invades into muscularis propia (pT2). B. 
Splenic flexure adenocarcinoma invades into submucosa (pT1). C. Sigmoid adenocarcinoma invades into 
muscularis propria (pT2). D. Lymph node showing metastatic adenocarcinoma. Five of 12 lymph nodes were 
positive in the resection specimen. 
CT scan abdomen/pelvis with oral and IV contrast: 4.2 x 2.7 cm mass at the cecum in region of terminal 
ileum (left). Areas of bowel wall thickening at distal rectosigmoid colon (right). 
Colonoscopy: Large spreading masslike lesion in cecum and ascending colon occupying at least half of the 
lumen (left). Another large spreading mass lesion over multiple folds in the sigmoid colon, approximately 
40 cm from the anal verge (right). 
IMAGES 
